HUDSON, Mass.—In February, Katahdin Industries, LLC, reported the sale of “substantially all of the assets” of Precision Coating to Integer Holdings Corporation. The transaction closed on January 7, 2025, according to a release from Katahdin Industries.
Precision Coating provides global Medtech customers with innovative products and services to enhance the surface functionality of patient-critical products. Since 2006, the company has built a highly specialized, proprietary coatings platform in the medical technology supply chain.
Precision Coating’s portfolio build, positioning, and growth trajectory were accelerated through five acquisitions, including CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), a merger with N2 Biomedical (2021), and Providence Texture (2023), the release stated. A nearly ten-fold increase in scale over the hold period was said to be further facilitated by investments in data systems, automation, materials development, and greenfield expansion in Costa Rica. The company currently operates out of four North American sites and one in Costa Rica.
“From the very beginning, we identified precise control over surface treatment as a key feature in the medical device manufacturing process,” Katahdin Industrie Chairman Tim Cabot, in the release. “We also saw a gap in the market to address unique coating-as-a-service needs for medical device customers and to position the company to become a fully capable contract manufacturing services provider for the full life cycle of each product we work on. Over time, our market focus has also allowed us to expand and enhance our specialized, high-value, and innovative application solutions, including GlideLine™, our proprietary fluoropolymer coatings for medical devices; MICRALOX®, our patented anodic coatings for re-usable medical instruments; and IonGuard®, our proprietary ion treatment for implants.”
Bill Ellerkamp, president of Precision Coating, said that the company is excited about its acquisition by Integer,
“We are proud of the strong and defensible position we’ve built in the proprietary coatings segment of the Medtech industry and the exceptional company culture we’ve created,” Ellerkamp said in the release. “Integer is uniquely positioned to capitalize on the strengths of our technologies, and our respective cultures are well aligned. We are confident in the future of Precision Coating as part of Integer.”
Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the company said it is “committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions.” Among the company’s brands are Greatbatch Medical® and Lake Region Medical®.